Inventor
DAOZHONG ZOU
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes24%
C07BGeneral methods of organic chemistry24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
LOC304%
PatentTitleYear
12,559,463Crystalline forms of a JAK2 inhibitor2026D1055400Pet carrier202412,049,446Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof202411,958,805Solid forms comprising an oxime ether compound, compositions and methods of use thereof202411,629,153Forms and compositions of a MK2 inhibitor202311,629,124Solid forms comprising an oxime ether compound, compositions and methods of use thereof202311,434,200Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof202211,186,556Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to CELGENE CORP (1)· patent assignee history
2021–2026Based in US· patent location history
2022–2024Patents assigned to NOVARTIS AG (4)· patent assignee history
2023Patents assigned to CELGENE CAR LLC (1)· patent assignee history
2024Patents assigned to ZOU DAOZHONG (1)· patent assignee history
2024Based in CN· patent location history
2026Patents assigned to IMPACT BIOMEDICINES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 4 | 2022–2024 |
| CELGENE CAR LLC | 1 | 2023 |
| CELGENE CORP | 1 | 2021 |
| IMPACT BIOMEDICINES INC | 1 | 2026 |
| ZOU DAOZHONGself | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2026 |
| CN | 1 | 2024 |